biological source
human blood
description
In Australia, this cell line is only supplied as live culture in flask due to the challenging recovery. Please store at 37°C upon receipt., Shipping condition: Ambient (Australia)
manufacturer/tradename
ECACC
packaging
tube of 5 μg 88081201-DNA-5UG, pkg of vial of cells 88081201-1VL
growth mode
Suspension
karyotype
Not specified
morphology
Monocyte
products
Not specified
receptors
Fc, C3b
technique(s)
cell culture | mammalian: suitable
relevant disease(s)
cancer
shipped in
dry ice
storage temp.
−196°C
General description
Application
THP 1 cell line human has been used to study:
- bactericidal activity of moxifloxacin against Staphylococcus aureus
- the effect of lipopolysaccharide-mediated inflammatory response in murine versus human cell lines
- the effects of purine nucleosides on the in vitro growth of Cryptosporidium parvum
- the change in gene expression after infection with Mycobacterium tuberculosis
- the induction of cytokines in the cell line in presence of antigens obtained from Clostridium difficile
Biochem/physiol Actions
Derived from the peripheral blood of a 1 year old male with acute monocytic leukaemia. THP-1 cells have Fc and C3b receptors and lack surface and cytoplasmic immunoglobulins. These cells also stain positive for α-napthhyl butyrate esterase, produce lysozymes and are phagocytic (both latex beads and sensitised erythrocytes). THP-1 cells can also restore the response of purified T lymphocytes to Concanavlin A, show increased CO2 production on phagocytosis and can be differentiated into macrophage-like cells using for example DMSO.
Human monocytic leukaemia
STR-PCR Data: Amelogenin: X,Y
CSF1PO: 11,13
D13S317: 13
D16S539: 11,12
D5S818: 11,12
D7S820: 10
THO1: 8,9.3
TPOX: 8,11
vWA: 16
CSF1PO: 11,13
D13S317: 13
D16S539: 11,12
D5S818: 11,12
D7S820: 10
THO1: 8,9.3
TPOX: 8,11
vWA: 16
Preparation Note
If starting from a frozen ampoule the cryoprotectant should be removed. Add thawed cells to a conical based centrifuge tube, e.g. 15ml tube, slowly add 4 ml of culture medium to the tube. Take a sample of the cell suspension, e.g. 100μl, to count cells. Centrifuge the cell suspension at low speed i.e. 100 - 150 x g for a maximum of 5 minutes. Remove medium and resuspend the cell pellet at a density of 3 - 5 x 100,000 cells/ml in fresh medium containing 20% serum. Incubate flask at 37°C; 5 - 7% CO2. Check daily. Keep flask in a vertical position until the cells reach the exponential phase of growth. This can take up to 7 days. Once the culture is established the serum concentration can be reduced to 10%. To keep the cells in exponential growth, maintain cultures between 3-8x100,000 cells/ml. Requires 5% DMSO and 95% fetal bovine serum (FBS) as cryoprotectant.
Please note: It is not uncommon for cell viability to drop after resuscitation and continue to decrease for a further 10-14 days before the cells begin to proliferate again. In terms of viable counts, this could mean a drop from around 5e+05 cells/ml post seeding (on resuscitation) to around 1e+05 cells/ml after around 10-14 days before cell counts start to increase in number again and then finally, proliferating at Log phase. You are advised not to disturb the cultures during this post-resuscitation recovery phase.
Please note: It is not uncommon for cell viability to drop after resuscitation and continue to decrease for a further 10-14 days before the cells begin to proliferate again. In terms of viable counts, this could mean a drop from around 5e+05 cells/ml post seeding (on resuscitation) to around 1e+05 cells/ml after around 10-14 days before cell counts start to increase in number again and then finally, proliferating at Log phase. You are advised not to disturb the cultures during this post-resuscitation recovery phase.
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). No licensing agreement is required when either this cell line or the DNA extracted from it are used for internal research purposes only. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to culturecollections@ukhsa.gov.uk.